After chemistry, the origins of biochemistry began at the end of the 19th century. The first major step was made when glycated hemoglobin, HbA1c, was found to be a precious index to follow an adapted antidiabetic treatment. This discovery led to the identification of cell receptors, present in vascular cells, leukocytes, neuronal cells. One such cell receptor, RAGE, has been shown to be a major contributor in cell alteration, the development of vascular complications in diabetes mellitus, ageing, and Alzheimer's disease. This book shows that the axis AGE-RAGE and the activation of RAGE by other ligands open up a possible new therapeutic approach to prevent complications of diabetes mellitus and ageing. As such, it will particularly appeal to chemists, biochemists, biologists, immunologists, nutritionists, doctors, cardiologists, and neurologists.The collection is the fruit of a collaboration of eminent experts (Ann Marie Schmidt is Professor of Medicine, New York University, USA; Marie-Paule Wautier PhD is an engineer at Institut National de la Sante et de la Recherche Medicale, Paris, France; Eric Boulanger is a Professor of medicine, Lille University, France; Peter Nawroth is a Professor of Internal Medicine at Heidelberg University, Germany; David Stern is Vice-Chancellor for Health Affairs, University of Tennessee, USA; Jean-Luc Wautier is an Emeritus Professor of Medicine, University Denis Diderot Paris, France) who have greatly contributed to the story of the Receptor for Advanced Glycation End products (RAGE).

After chemistry, the origins of biochemistry began at the end of the 19th century. The first major step was made when glycated hemoglobin, HbA1c, was found to be a precious index to follow an adapted antidiabetic treatment. This discovery led to the identification of cell receptors, present in vascular cells, leukocytes, neuronal cells. One such cell receptor, RAGE, has been shown to be a major contributor in cell alteration, the development of vascular complications in diabetes mellitus, ageing, and Alzheimer's disease. This book shows that the axis AGE-RAGE and the activation of RAGE by other ligands open up a possible new therapeutic approach to prevent complications of diabetes mellitus and ageing. As such, it will particularly appeal to chemists, biochemists, biologists, immunologists, nutritionists, doctors, cardiologists, and neurologists.The collection is the fruit of a collaboration of eminent experts (Ann Marie Schmidt is Professor of Medicine, New York University, USA; Marie-Paule Wautier PhD is an engineer at Institut National de la Sante et de la Recherche Medicale, Paris, France; Eric Boulanger is a Professor of medicine, Lille University, France; Peter Nawroth is a Professor of Internal Medicine at Heidelberg University, Germany; David Stern is Vice-Chancellor for Health Affairs, University of Tennessee, USA; Jean-Luc Wautier is an Emeritus Professor of Medicine, University Denis Diderot Paris, France) who have greatly contributed to the story of the Receptor for Advanced Glycation End products (RAGE).